Abstract
Over 160+ pages dedicated to tissue engineering and stem cell analysis.
The market potential of this technology is so huge that revenues may be in
excess of $10 billion by 2013. This is a market that you should be part of -
NOW!! With a complex regulatory structure still to overcome, yet continued
high level investment, many of your competitors are aware of the commercial
opportunities within Tissue Engineering & Stem Cell Technology.
Tissue engineering, the manufacture of complete tissues outside of the body
ready for future transplant use, is already with us, including several types
of replacement skin and a cartilage substitute. The estimated market for
future tissue engineered products including the regeneration of bone,
cartilage, and other connective structural treatments is worth approximately
$5 billion worldwide.
The report ' Tissue Engineering and Stem Cell Technology Report 2007' will
analyse these two highly lucrative markets for you and will include:
- 1. An in-depth explanation of the physiology behind stem cell technology
- 2. A listing of over 100 companies involved and a survey of the principle
companies in stem cell development
- 3. An examination of the products in development & the likely clinical
areas for future treatments
- 4. An in-depth assessment of the future markets delivered to you today
- 5. A thorough examination of the ethical and regulatory aspects behind
stem cell research
- 6. A detailed analysis of the financial position of the market as it
stands and future projections of growth
Methodology
The information contained in this report is from primary industry sources.
This includes one-on-one interviews with companies, with governmental bodies
and academic institutions. Analysis has also been drawn from company reports,
whether annual financial returns or white papers. The author of this report
has dealt with over 50+ companies and industry contacts to assist on the
production of this report.
Targeted directly at you this report is designed to be used primarily by
executives, investors, venture capitalists, and business development managers
and analysts involved in the pharmaceutical or biotechnology areas that may
have an interest in stem cell technology.
This market has grown rapidly since the isolation of embryonic stem cells in
1998. With the technologies that impact stem cells catching up to the rate of
research, now is your last chance to corner a section of this market.
It is the multifaceted role of stem cells in a whole wide range of diseases
that accounts for this huge potential. The diseases that stem cell technology
may offer treatments for includes:
- 1. Parkinson' s Disease
- 2. Diabetes
- 3. Chronic Heart Disease
- 4. Kidney Disease
- 5. Liver Failure
- 6. Cancer
- 7. Spinal Cord Injury
- 8. Multiple Sclerosis
- 9. Alzheimer' s Disease
- 10. Gene Therapy
Why you must buy this report:
The pharmaceutical industry has been seeking the next blockbuster drug, yet it
appears as though these might not be as profligate as they have been in the
past. However, the tissue engineering & stem cell treatment hold promise. This
report analyses the current situation in the market and assesses the potential
of work that are currently in the pipeline. You and your company should be
part of this market, and you could be by placing your order immediately.
Unique benefits to you when you order this report
- Immediate access through our exclusive Reading Room
- You can access your report whichever country you are in without using hard
drive space
- Primary research throughout. You will not find this information anywhere
else
- Report stored in your reading room for ever
- Full searchable report when you buy the company or corporate editions
- Copies can be printed off for offline reading
- Packed with charts, analysis, figures, graphs and tables
If you buy one report this year make sure it is the report that will guarantee
your success for the forthcoming years. Order this report now
View Cart
